NCT06592495View on ClinicalTrials.gov

Bioepuivalence Study for the Safety and the Pharmacokinetics of DWJ1589 and DWC202315

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

October 31, 2025

Conditions
Healthy Volunteers
Interventions
DRUG

Period 1

DWJ1589 or DWC202315

DRUG

Period 2

DWJ1589 or DWC202315

DRUG

Period 3

DWJ1589 or DWC202315

DRUG

Period 4

DWJ1589 or DWC202315

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY